SCHEMBL14416565

SCHEMBL14416565

COC(=O)NCc1ccc(-c2cc(C(=O)NC(C)(C)C)nn2-c2cccnc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MARS1 P56192 3/20 0.51
CACNA1G O43497 3/20 0.50
CACNA1H O95180 3/20 0.50
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49
RPA1 P27694 6/20 0.44
DHODH Q02127 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SLC16A3 O15427 1/20 0.42
SLC16A1 P53985 1/20 0.42
NAMPT P43490 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14416559 0.89 CNR1 (0.47) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5523089 0.86 CNR1 (0.53) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5526243 0.85 CNR1 (0.49) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5522940 0.82 NAMPT (0.47) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5529778 0.81 CNR1 (0.52) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5529584 0.80 CNR1 (0.49) MARS1CNR1CNR2RPA1DHODH
SCHEMBL5531835 0.80 CNR1 (0.51) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5526417 0.79 CNR1 (0.48) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5525413 0.79 CNR1 (0.48) MARS1CACNA1GCACNA1HCNR1CNR2
SCHEMBL5526193 0.77 CNR1 (0.50) MARS1CACNA1GCACNA1HCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 MARS1 2982/4885CACNA1G 3126/4885CACNA1H 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.